Literature DB >> 96343

Prevention of the Wernicke-Korsakoff syndrome: a cost-benefit analysis.

B S Centerwall, M H Criqui.   

Abstract

The Wernicke-Korsakoff syndrome is a thiamine-deficiency disorder occurring primarily among alcoholics. To determine the economic feasibility of preventing this disease by fortification of alcoholic beverages with thiamine, we compared the cost of fortification with the cost of institutionalizing alcoholics with the disorder. The estimated annual incidence of institutionalization is eight per million adult population. The cost of long-term institutionalization, discounted to present value, is $70 million per year. The cost of adequately fortifying alcoholic beverages is estimated to range from $3 million per year if allithiamines are used, to as much as $17 million per year if thiamine hydrochloride proves necessary. Thus, the cost-benefit ratio may range from 1:23 to 1:4. It is economically advantageous to prevent the Wernicke-Korsakoff syndrome by fortification of alcoholic beverages with thiamine. The stability, safety and marketability of thiamine and the allithiamines in alcoholic beverages should be studied further.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 96343     DOI: 10.1056/NEJM197808102990605

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  13 in total

1.  The prevalence of the Wernicke-Korsakoff syndrome in Sydney, Australia: a prospective necropsy study.

Authors:  C Harper; J Gold; M Rodriguez; M Perdices
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-02       Impact factor: 10.154

Review 2.  Vitamins: an evolutionary perspective.

Authors:  C R Scriver
Journal:  J Inherit Metab Dis       Date:  1985       Impact factor: 4.982

Review 3.  The William Allan Memorial Award address: On phosphate transport and genetic screening. "Understanding backward--living forward" in human genetics.

Authors:  C R Scriver
Journal:  Am J Hum Genet       Date:  1979-05       Impact factor: 11.025

Review 4.  The physician's role.

Authors:  R E Kendell
Journal:  CMAJ       Date:  1990-11-15       Impact factor: 8.262

5.  Prevention and cost containment.

Authors:  M Susser
Journal:  Bull N Y Acad Med       Date:  1980 Jan-Feb

6.  The incidence of Wernicke's encephalopathy in Australia--a neuropathological study of 131 cases.

Authors:  C Harper
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-07       Impact factor: 10.154

7.  Loss of muscarinic cholinergic receptors from the temporal cortex of alcohol abusers.

Authors:  G Freund; W E Ballinger
Journal:  Metab Brain Dis       Date:  1989-06       Impact factor: 3.584

8.  Pennsylvania's domiciliary care experiment: II. Cost-benefit implications.

Authors:  H S Ruchlin; J N Morris
Journal:  Am J Public Health       Date:  1983-06       Impact factor: 9.308

Review 9.  Window panes of eternity. Health, disease, and inherited risk.

Authors:  C R Scriver
Journal:  Yale J Biol Med       Date:  1982 Sep-Dec

10.  Wernicke's encephalopathy.

Authors:  C E Handler; G D Perkin
Journal:  J R Soc Med       Date:  1983-05       Impact factor: 18.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.